A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study

NCT05217108 | Active Not Recruiting

• 2 other identifiers: 2021-1014NCI-2022-00101
• Study Type: interventional
• Target: 228
• Locations: 1 country
• Sites: 1

Brief Summary

To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.

Conditions

Life Style; Healthy Lifestyle

Outcome Measures

Primary Outcomes (1)

• Daily minutes in sedentary behavior based on Fitbit data.

  through study completion, an average of 1 year

Study Arms (1)

Fit Bit (Study Groups)

OTHER

Participants wear a Fitbit every day for 8 weeks to record the number of steps you take

Device: FitBit

Interventions

FitBit DEVICE

All participants in each study group will receive a Fitbit. Participants will be asked to wear a Fitbit every day for 8 weeks to record the number of steps you take

Fit Bit (Study Groups)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \>18 years old
• owns a smart phone
• has access to WiFi or willing to use mobile data
• has an email address or willing to create an email address
• able to read and understand English;
• able to give informed consent;
• willing to receive text messages and complete brief questionnaires on their smart phone
• self-reports sedentary behavior (\> 6 hours/day of sitting time).

You may not qualify if:

• unwilling to have sedentary behavior and activity tracked
• unable to walk without ambulatory assistance device (i.e. cane or walker) or due to underlying medical condition
• MD Anderson employees that report to the Principal Investigators of this study
• family or household member already enrolled into study
• not sedentary based on \< 6 hours/day of sitting time, and (6) currently participating in a weight management or exercise study or program

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• M D Anderson Cancer Center

Study Officials

• Karen Basen-Engquist, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 5, 2022
• First Posted: February 1, 2022
• Study Start: January 5, 2022
• Primary Completion (Estimated): October 31, 2026
• Study Completion (Estimated): October 31, 2026
• Last Updated: May 22, 2026

Record last verified: 2026-05

Locations

US (1)